CD69 limits the severity of cardiomyopathy after autoimmune myocarditis

Circulation

Volumn 122, Issue 14, 2010, Pages 1396-1404

  Cruz Adalia, Aranzazu ^a   Jiménez Borreguero, Luis Jesús ^b,c   Ramírez Huesca, Marta ^a   Chico Calero, Isabel ^e   Barreiro, Olga ^a   López Conesa, Erica ^a   Fresno, Manuel ^e   Sánchez Madrid, Francisco ^a,d   Martín, Pilar ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b Department of Atherothrombosis and Cardiovascular Imaging ^*  (Spain)

^c Servicio de Cardiologia   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e CSIC   (Spain)

Author keywords

cardiomyopathy; echocardiography; immune system; inflammation; myocarditis

Indexed keywords

CD69 ANTIGEN; INTERLEUKIN 17;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; AXILLARY LYMPH NODE; BODY WEIGHT; CARDIOMYOPATHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART WEIGHT; IMMUNE RESPONSE; INFLAMMATION; ISOLATED HEART; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINUS NODE; TH17 CELL; TRANSTHORACIC ECHOCARDIOGRAPHY; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNE DISEASES; CROSSES, GENETIC; ENDOMYOCARDIAL FIBROSIS; FEMALE; FLOW CYTOMETRY; HUMANS; LECTINS, C-TYPE; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDITIS; MYOSIN HEAVY CHAINS; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX; SPLEEN;

EID: 77958470132     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.952820     Document Type: Article

References (44)

1. Eriksson U, Penninger JM. Autoimmune heart failure: new under-standings of pathogenesis. Int J Biochem Cell Biol. 2005;37:27-32.
2. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343: 1388-1398.
3. Kawai C From myocarditis to cardiomyopathy: mechanisms of inflam-mation and cell death: learning from the past for the future. Circulation. 1999;99:1091-1100.
4. Cihakova D, Rose NR. Pathogenesis of myocarditis and dilated cardio-myopathy. Adv Immunol. 2008;99:95-114.
5. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopatho-genetic features at diagnosis. Eur Heart J. 2007;28:1326-1333.
6. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118:639-648.
7. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity. 2008;41:35-45.
8. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. 2001;16:175-186.
9. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630-3636.
10. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. 2003;9:1484-1490.
11. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation. 2001;104:3145-3151.
12. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med. 2006;203:2009-2019.
13. Sonderegger I, Rohn TA, Kurrer MO, Iezzi G, Zou Y, Kastelein RA, Bachmann MF, Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol. 2006; 36:2849-2856.
14. Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation. 2001; 103:18-21.
15. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myo-carditis: induction by IL-12 and protection by IFN-gamma. J Immunol. 2001;167:5464-5469.
16. Afanasyeva M, Georgakopoulos D, Belardi DF, Bedja D, Fairweather D, Wang Y, Kaya Z, Gabrielson KL, Rodriguez ER, Caturegli P, Kass DA, Rose NR. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci US A. 2005;102:180-185.
17. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, Dirnhofer S, Leimenstoll B, Blyszczuk P, Dong C, Mueller C, Hunziker L, Eriksson U. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experi-mental autoimmune myocarditis. J Immunol. 2008;180:2686-2695.
18. Testi R, Phillips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol. 1989;143:1123-1128.
19. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte acti-vation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med. 1993;178: 537-547.
20. Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family ofnatural killer cell activation antigens. Eur J Immunol. 1993;23:1643-1648.
21. Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today. 1994;15:479-483.
22. Garcia-Monzon C, Moreno-Otero R, Pajares JM, Garcia-Sanchez A, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology. 1990;98:1029-1035.
23. Laffon A, Garcia-Vicuna R, Humbria A, Postigo AA, Corbi AL, de Landazuri MO, Sanchez-Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest. 1991;88:546-552.
24. Sancho D, Gomez M, Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005;26: 136-140.
25. Sancho D, Gomez M, Viedma F, Esplugues E, Gordon-Alonso M, Garcia-Lopez MA, de la Fuente H, Martinez AC, Lauzurica P, Sanchez-Madrid F. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest. 2003;112:872-882.
26. Lamana A, Sancho D, Cruz-Adalia A, del Hoyo GM, Herrera AM, Feria M, Diaz-Gonzalez F, Gomez M, Sanchez-Madrid F. The role of CD69 in acute neutrophil-mediated inflammation. Eur J Immunol. 2006;36: 2632-2638.
27. Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol. 2006;36:2857-2867.
28. Lauzurica P, Sancho D, Torres M, Albella B, Marazuela M, Merino T, Bueren JA, Martinez AC, Sanchez-Madrid F. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood. 2000;95:2312-2320.
29. Afanasyeva M, Georgakopoulos D, Belardi DF, Ramsundar AC, Barin JG, Kass DA, Rose NR. Quantitative analysis of myocardial inflam-mation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am J Pathol. 2004;164:807-815.
30. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJ, Rose NR. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol. 2005;174:261-269.
31. Pummerer CL, Luze K, Grassl G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu N. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest. 1996;97:2057-2062.
32. Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res. 2003;60:5-10.
33. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-1538.
34. Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Luscher TF, Eriksson U. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflam-matory dilated cardiomyopathy. Circ Res. 2009;105:912-920.
35. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol. 2001;159:193-203.
36. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6: 1133-1141.
37. Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, Berg M, Talor MV, Baldeviano GC, Frisancho S, Gabrielson K, Bedja D, Rose NR. Interleukin-13 protects against experimental autoimmune myo-carditis by regulating macrophage differentiation. Am J Pathol. 2008;172: 1195-1208.
38. Daniels MD, Hyland KV, Wang K, Engman DM. Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via acti-vation ofTh1 and Th17 immunity. Autoimmunity. 2008;41:490-499.
39. Knowlton KU, Badorff C. The immune system in viral myocarditis: maintaining the balance. Circ Res. 1999;85:559-561.
40. Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, Moncada S, Liew FY, Lowenstein CJ. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci USA. 1998;95:2469-2474.
41. Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671-2678.
42. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
43. London B. Cardiac arrhythmias: from (transgenic) mice to men. J Car-diovasc Electrophysiol. 2001;12:1089-1091.
44. Berul CI. Electrophysiological phenotyping in genetically engineered mice. Physiol Genomics. 2003;13:207-216.